Pulmonary Infections in Adults: Nosocomial Pneumonia

Area of Science:

• Critical Care Medicine
• Infectious Diseases
• Pulmonology

Background:

• Nosocomial pneumonia, encompassing hospital-acquired pneumonia (HAP) and ventilator-associated pneumonia (VAP), presents significant morbidity and mortality risks.
• HAP and VAP are defined by their occurrence post-hospital admission or initiation of mechanical ventilation, respectively.
• Mortality rates for VAP and ventilated HAP range from 15% to 30%, highlighting the severity of these conditions.

Purpose of the Study:

• To outline the diagnostic criteria for nosocomial pneumonia.
• To detail optimal management strategies, including pathogen identification and antimicrobial therapy.
• To present evidence-based VAP prevention methods.

Main Methods:

• Diagnosis relies on identifying new pulmonary infiltrates coupled with clinical signs of infection (fever, purulent sputum, leukocytosis, hypoxemia).
• Management involves prompt pathogen identification and early empiric antibiotic therapy.
• Treatment de-escalation based on identified pathogens and a standard 7-day course for clinically improving patients.

Main Results:

• Effective VAP prevention strategies include meticulous hand hygiene, patient positioning, and oral care.
• Subglottic secretion drainage and judicious use of stress-ulcer prophylaxis are crucial.
• Early targeted antimicrobial therapy and de-escalation contribute to optimal outcomes.

Conclusions:

• Nosocomial pneumonia requires prompt diagnosis and tailored management strategies.
• Implementing comprehensive VAP prevention protocols is essential for reducing infection rates.
• Adherence to recommended treatment durations and de-escalation improves patient recovery and survival.